NCT03979248View on ClinicalTrials.gov

A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 16, 2019

Primary Completion Date

July 7, 2019

Study Completion Date

July 7, 2019

Conditions
Healthy
Interventions
DRUG

BMS-986165

Specified dose on specified days.

DRUG

Rabeprazole

Specified dose on specified days.

Trial Locations (1)

9728 NZ

PRA Health Sciences - Netherlands, Groningen

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03979248 - A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and Complete The Drug is Absorbed Into the Body of Healthy Participants | Biotech Hunter | Biotech Hunter